Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

[1]  P. Chanson,et al.  Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study. , 2013, Human molecular genetics.

[2]  E. Fonseca,et al.  MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. , 2012, European journal of endocrinology.

[3]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[4]  A. Miyauchi,et al.  Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database , 2012, Clinical endocrinology.

[5]  A. Calender.  Multiple endocrine neoplasia type 1 (MEN1) , 2011 .

[6]  D. Marsh,et al.  Multiple endocrine neoplasia: types 1 and 2. , 2011, Advances in oto-rhino-laryngology.

[7]  E. Roti,et al.  BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. , 2009, European journal of endocrinology.

[8]  M. Brandi,et al.  Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? , 2009, The Journal of clinical endocrinology and metabolism.

[9]  L. Bujanda,et al.  [Clinical and molecular features in a family with multiple endocrine neoplasia type-1 syndrome]. , 2008, Gastroenterologia y hepatologia.

[10]  S. Ellard,et al.  Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1 , 2008, Clinical endocrinology.

[11]  R. Thakker,et al.  Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene , 2008, Human mutation.

[12]  L. Bujanda,et al.  [Clinical and molecular features in a family with multiple endocrine neoplasia type-1 syndrome]. , 2008, Gastroenterologia y hepatologia.

[13]  B. Skogseid,et al.  Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  鈴木眞一.  多発性内分泌腺腫症1型 (Multiple Endocrine Neoplasia type 1 : MEN1) , 2007 .

[15]  T. Obara,et al.  A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. , 2006, Japanese journal of clinical oncology.

[16]  J. Rehfeld,et al.  Characteristics of the Danish families with multiple endocrine neoplasia type 1 , 2006, Molecular and Cellular Endocrinology.

[17]  A. Bottoni,et al.  Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  T. Obara,et al.  Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1. , 2004, Cancer letters.

[19]  B. Zehnbauer,et al.  Clinical Genetic Testing and Early Surgical Intervention in Patients With Multiple Endocrine Neoplasia Type 1 (MEN 1) , 2004, Annals of surgery.

[20]  J. Benítez,et al.  Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients , 2003, Journal of medical genetics.

[21]  R. Thakker,et al.  Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions , 2002, Clinical endocrinology.

[22]  G. Sassolas,et al.  Pituitary Disease in MEN Type 1 ( MEN 1 ) : Data from the France-Belgium MEN 1 , 2002 .

[23]  S. Ellard,et al.  Multiple endocrine neoplasia type 1Burin from Mauritius: A novel MEN 1 mutation1 , 2001 .

[24]  N. Hayward,et al.  Identification of MEN1 gene mutations in families with MEN 1 and related disorders , 2000, British Journal of Cancer.

[25]  N. Hayward,et al.  Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours , 2000, British Journal of Cancer.

[26]  B. Boehm,et al.  Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region. , 2000, The Journal of endocrinology.

[27]  P. Chanson,et al.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. , 1998, American journal of human genetics.

[28]  H. Futami,et al.  A Large Germline Deletion of the MEN1 Gene in a Family with Multiple Endocrine Neoplasia Type 1 , 1998, Japanese journal of cancer research : Gann.